Brawn Biotech Limited - pharma in Delhi, Delhi, India. FY 2026 financials and compliance.
CIN L74899DL1985PLC022468 Incorporated 07 November 1985 ROC Delhi HQ Delhi, Delhi, India
Active Listed - BSE: 530207 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹16.98 Cr
▲ 26.09% YoY
EBITDA · FY 2026
₹12.75 Lakh
▲ 107.59% YoY
Net profit · FY 2026
₹94.05 Lakh
▲ 152.31% YoY
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
None
Satisfied ₹30.28 Lakh
Company age
41 yrs
Est. 1985
Last financials
Mar 2025
Balance sheet date

About Brawn Biotech Limited

Data last updated: 23 December 2025

Brawn Biotech Limited is a public limited company based in Delhi, Delhi, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 07 November 1985, the company has been in operation for over 41 years.

Registered with ROC Delhi under CIN L74899DL1985PLC022468. Listed on BSE: 530207.

Capital: an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹3 Cr. Formerly known as Brawn Pharmaceuticals Limited and Brawn Pharmaceuticals Private Limited. It is led by directors including Brij Raj Gupta and Brij Bala Gupta.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: First Floor C – 64 Lagpat Nagar – 1, Delhi, Delhi, India – 110024.

As per the financials filed for FY 2025, the company reported a revenue of ₹13.56 Cr, a decline of 18% compared to the previous year.

The company is associated with 2 brands - Brawnpharma, Brawn Biotech. As per MCA filings, the company has satisfied charges of ₹30.28 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brawnbiotech.com.

Company Details of Brawn Biotech Limited
CIN L74899DL1985PLC022468
Registration Number 022468
Incorporation Date 07 November 1985
ROC Delhi
Listing Status Listed (BSE: 530207)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Social Media
  • Registered Address
    First Floor C – 64 Lagpat Nagar – 1, Delhi, Delhi, India – 110024
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Brawn Biotech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Brawn Biotech Limited report

Financials, compliance, directors, charges, ownership and filings for Brawn Biotech Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Brawn Biotech Limited

Brawn Biotech Limited has undergone 4 name changes throughout its history. The current legal name is Brawn Biotech Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Brawn Biotech Limited Current
Brawn Pharmaceuticals Limited Previous
Brawn Pharmaceuticals Private Limited Previous
Brawn Pharmaceuticals Ltd Previous
Brawn Pharmaceuticals P Ltd Previous

Associated Brands with Brawn Biotech Limited

Brawn Biotech Limited operates two associated brands: Brawnpharma and Brawn Biotech. These brands represent Brawn Biotech Limited's diversified market presence and brand portfolio.

Brand Description Website
Pharmaceutical formulations are distributed across major healthcare segments. brawnbiotech.com
Pharmaceutical products are developed and distributed by Brawnpharma. brawnpharma.com

Competitors & Alternatives of Brawn Biotech Limited

Brands and companies operating in the same space as Brawn Biotech Limited include Entero Healthcare, AmerisourceBergen, Keimed and 5 more.

Competitor Description Location Founded
Entero Healthcare Entero Healthcare India's leading healthcare products distribution platform Mumbai, India, India 2018
AmerisourceBergen AmerisourceBergen Pharmaceutical distribution and supply chain services are provided globally. Chesterbrook, United States, United States 1985
Keimed Keimed Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. Hyderabad, India, India 2000
Sandor Medicaids Sandor Medicaids Provider of medical equipment, devices, and drugs distribution services Hyderabad, India, India 1995
Dipna Pharmachem Dipna Pharmachem Distributor of pharmaceutical raw materials Ahmedabad, India, India 2011
Mahaveer Medi Sales Mahaveer Medi Sales Serves as a distributor of a wide range of pharmaceutical drugs. Bengaluru, India, India 2016
Salas Pharmaceuticals Salas Pharmaceuticals A healthcare company specializing in multidisciplinary engineering and technical services. Patna, India, India 2009
Kaushal Pharma Kaushal Pharma Distributes pharmaceuticals to over 1500 retailers and wholesalers in Kolkata. Kolkata, India, India 1970

Business Activity of Brawn Biotech Limited

Brawn Biotech Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading *********

Auditor Details of Brawn Biotech Limited

Brawn Biotech Limited is audited by RAJIV UDAY & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
RAJIV UDAY & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-05-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Brawn Biotech Limited

Brawn Biotech Limited is currently managed by 6 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Brij Raj Gupta Director 07 Nov 1985 40 Years 8 Months Current
Brij Bala Gupta Director 24 Nov 2004 21 Years 7 Months Current
Mayank Jain Director 27 Aug 2024 1 Years 10 Months Current
Pooja Jha Director 27 Aug 2024 1 Years 10 Months Current

Financials of Brawn Biotech Limited FY 2026 filings available

Brawn Biotech Limited reported revenue of ₹16.98 Cr (up 26.09% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹16.98 Cr ▲ 26.09%
Profit · FY 2026
₹94.05 Lakh ▲ 152.31%
EBITDA · FY 2026
₹12.75 Lakh ▲ 107.59%
Revenue₹ Cr · Standalone0255075FY 2019: ₹65 Cr65.2FY 2019FY 2020: ₹50 Cr · -23.9% YoY49.6-23.9%FY 2020FY 2021: ₹35 Cr · -29.5% YoY35-29.5%FY 2021FY 2022: ₹9 Cr · -75.4% YoY8.6-75.4%FY 2022FY 2023: ₹22 Cr · +157.9% YoY22.2+157.9%FY 2023FY 2024: ₹16 Cr · -25.8% YoY16.5-25.8%FY 2024FY 2025: ₹13 Cr · -18.4% YoY13.5-18.4%FY 2025FY 2026: ₹17 Cr · +26.1% YoY17+26.1%FY 2026
Net Profit₹ Cr · Standalone-2-1012FY 2019: ₹1 Cr1.3FY 2019FY 2020: ₹1 Cr · -55.6% YoY0.6-55.6%FY 2020FY 2021: ₹1 Cr (loss) · -193.1% YoY-0.6FY 2021FY 2022: ₹2 Cr (loss) · -198.7% YoY-1.6FY 2022FY 2023: ₹1 Cr (loss) · +47.2% YoY-0.9FY 2023FY 2024: ₹2 Cr (loss) · -77.9% YoY-1.5FY 2024FY 2025: ₹2 Cr (loss) · -16.4% YoY-1.8FY 2025FY 2026: ₹1 Cr · +152.3% YoY0.9+152.3%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0246Q1'25: ₹4 Cr4.1Q1'25Q2'25: ₹3 Cr3.3Q2'25Q3'25: ₹4 Cr3.8Q3'25Q4'25: ₹2 Cr2.3Q4'25Q1'26: ₹6 Cr · +42.7% YoY5.8+42.7%Q1'26Q2'26: ₹5 Cr · +48.4% YoY4.9+48.4%Q2'26Q3'26: ₹4 Cr · +12.2% YoY4.3+12.2%Q3'26Q4'26: ₹2 Cr · -12.5% YoY2-12.5%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹16.98 Cr ₹13.47 Cr ₹16.49 Cr ₹22.23 Cr ₹8.62 Cr ₹34.98 Cr ₹49.62 Cr ₹65.18 Cr
Other Income ₹45.4 Lakh ₹9.33 Lakh ₹8.81 Lakh ₹92,000 ₹37,000 ₹30.93 Lakh ₹17.09 Lakh ₹73.78 Lakh
Total Income ₹17.43 Cr ₹13.56 Cr ₹16.58 Cr ₹22.24 Cr ₹8.62 Cr ₹35.28 Cr ₹49.79 Cr ₹65.92 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹1.64 Cr ₹0 ₹0
Purchases of Stock-in-Trade ₹14.11 Cr ₹16.38 Cr ₹15.59 Cr ₹19.24 Cr ₹11.05 Cr ₹28.25 Cr ₹42.15 Cr ₹58.49 Cr
Changes in Inventories ₹40.49 Lakh -₹4.45 Cr -₹1.23 Cr -₹6.77 Lakh -₹4.47 Cr ₹13.2 Lakh -₹5.02 Lakh ₹90,000
Employee Benefit Expense ₹68.36 Lakh ₹1.13 Cr ₹1.4 Cr ₹1.4 Cr ₹1.8 Cr ₹2.36 Cr ₹3.08 Cr ₹3.02 Cr
Finance Costs ₹45,000 ₹37,000 ₹38,000 ₹82,000 ₹6.25 Lakh ₹3.69 Lakh ₹4.94 Lakh ₹6.14 Lakh
Depreciation & Amortisation ₹12.2 Lakh ₹11.46 Lakh ₹9.94 Lakh ₹10.91 Lakh ₹5.33 Lakh ₹3.35 Lakh ₹3.47 Lakh ₹3.2 Lakh
Other Expenses ₹2.1 Cr ₹2.18 Cr ₹2.26 Cr ₹1.96 Cr ₹2.24 Cr ₹3.19 Cr ₹3.7 Cr ₹2.5 Cr
Total Expenses ₹17.43 Cr ₹15.36 Cr ₹18.13 Cr ₹22.65 Cr ₹10.74 Cr ₹35.64 Cr ₹48.97 Cr ₹64.11 Cr
Profit Before Exceptional Items & Tax ₹10,000 -₹1.8 Cr -₹1.54 Cr -₹41.16 Lakh -₹2.12 Cr -₹35.99 Lakh ₹81.98 Lakh ₹1.81 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹10,000 -₹1.8 Cr -₹1.54 Cr -₹41.16 Lakh -₹2.12 Cr -₹35.99 Lakh ₹81.98 Lakh ₹1.81 Cr
Total Tax Expense -₹93.95 Lakh ₹0 ₹0 ₹45.66 Lakh -₹47.34 Lakh ₹19.07 Lakh ₹22.85 Lakh ₹47.24 Lakh
Net Profit ₹94.05 Lakh -₹1.8 Cr -₹1.54 Cr -₹86.82 Lakh -₹1.64 Cr -₹55.06 Lakh ₹59.13 Lakh ₹1.33 Cr
Other Comprehensive Income ₹3.65 Lakh ₹3.73 Lakh ₹28,000 -₹4.3 Lakh ₹6.96 Lakh ₹8.44 Lakh ₹1.3 Lakh ₹5.53 Lakh
Total Comprehensive Income ₹97.7 Lakh -₹1.76 Cr -₹1.54 Cr -₹91.12 Lakh -₹1.57 Cr -₹46.62 Lakh ₹60.43 Lakh ₹1.39 Cr
EBITDA (computed) ₹12.75 Lakh -₹1.68 Cr -₹1.44 Cr -₹29.43 Lakh -₹2 Cr -₹28.95 Lakh ₹90.39 Lakh ₹1.9 Cr
Basic EPS ₹3.26 ₹-5.87 ₹-5.14 ₹-3.04 ₹-5.25 ₹-1.55 ₹2.01 ₹4.63
Diluted EPS ₹3.26 ₹-5.87 ₹-5.14 ₹-3.04 ₹-5.25 ₹-1.55 ₹2.01 ₹4.63
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹20.86 Cr ₹20.49 Cr ₹14.59 Cr ₹14.53 Cr ₹13.78 Cr ₹13.87 Cr ₹20.29 Cr ₹22.52 Cr
Non-current Assets ₹3.74 Cr ₹2.99 Cr ₹1.45 Cr ₹1.13 Cr ₹1.6 Cr ₹1.15 Cr ₹1.08 Cr ₹76.74 Lakh
Current Assets ₹17.12 Cr ₹17.5 Cr ₹13.14 Cr ₹13.4 Cr ₹12.19 Cr ₹12.73 Cr ₹19.21 Cr ₹21.75 Cr
Property, Plant & Equipment ₹36.46 Lakh ₹46.04 Lakh ₹33.34 Lakh ₹37.25 Lakh ₹38.59 Lakh ₹14.23 Lakh ₹17.58 Lakh ₹19.17 Lakh
Inventories ₹10.06 Cr ₹10.47 Cr ₹6.02 Cr ₹4.79 Cr ₹4.72 Cr ₹25.68 Lakh ₹38.89 Lakh ₹33.86 Lakh
Trade Receivables ₹3.55 Cr ₹3.41 Cr ₹3.88 Cr ₹5.32 Cr ₹2.81 Cr ₹9.28 Cr ₹15 Cr ₹16.46 Cr
Cash & Equivalents ₹28.06 Lakh ₹19.95 Lakh ₹39.73 Lakh ₹43.88 Lakh ₹22.46 Lakh ₹39.63 Lakh ₹39.99 Lakh ₹54.47 Lakh
Equity (Net Worth) ₹4.34 Cr ₹3.36 Cr ₹5.07 Cr ₹6.31 Cr ₹7.22 Cr ₹8.8 Cr ₹9.26 Cr ₹8.66 Cr
Equity Share Capital ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Debt (computed) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Current Liabilities ₹15.17 Cr ₹9.33 Cr ₹6.51 Cr ₹8.05 Cr ₹6.32 Cr ₹4.9 Cr ₹10.92 Cr ₹13.7 Cr
Total Liabilities ₹16.52 Cr ₹17.13 Cr ₹9.52 Cr ₹8.22 Cr ₹6.56 Cr ₹5.08 Cr ₹11.03 Cr ₹13.86 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹11.19 Lakh ₹4.75 Lakh -₹2.34 Lakh ₹30.16 Lakh ₹18.78 Lakh
Investing Cash Flow -₹2.62 Lakh -₹24.16 Lakh -₹1.21 Lakh -₹9.56 Lakh -₹29.7 Lakh
Financing Cash Flow -₹45,000 -₹37,000 -₹37,900 ₹82,000 -₹6.25 Lakh
Capital Expenditure ₹2.62 Lakh ₹24.16 Lakh ₹1.21 Lakh ₹9.56 Lakh ₹29.7 Lakh
Free Cash Flow (computed) ₹8.57 Lakh -₹19.41 Lakh -₹3.55 Lakh ₹20.6 Lakh -₹10.92 Lakh
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹8.12 Lakh -₹19.78 Lakh -₹3.93 Lakh ₹21.42 Lakh -₹17.16 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹1.98 Cr ₹4.31 Cr ₹4.89 Cr ₹5.8 Cr ₹2.26 Cr ₹3.84 Cr ₹3.3 Cr ₹4.06 Cr
Other Income ₹18.09 Lakh ₹9.1 Lakh ₹9.12 Lakh ₹9.09 Lakh ₹9.12 Lakh ₹8,000 ₹13,000 ₹0
Total Income ₹2.16 Cr ₹4.4 Cr ₹4.98 Cr ₹5.89 Cr ₹2.35 Cr ₹3.85 Cr ₹3.3 Cr ₹4.06 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹1.3 Cr ₹3.54 Cr ₹5.36 Cr ₹3.91 Cr ₹3.18 Cr ₹8 Cr ₹2.45 Cr ₹2.75 Cr
Changes in Inventories ₹41.32 Lakh ₹14.77 Lakh -₹1.21 Cr ₹1.05 Cr -₹1.23 Cr -₹4.54 Cr ₹31.69 Lakh ₹1.01 Cr
Employee Benefit Expense ₹19.21 Lakh ₹14.08 Lakh ₹14.55 Lakh ₹20.52 Lakh ₹22.49 Lakh ₹20.93 Lakh ₹28.16 Lakh ₹41.05 Lakh
Finance Costs ₹23,000 ₹1,000 ₹3.1 Lakh ₹3,000 ₹21,000 ₹1,000 ₹15,000 ₹0
Depreciation & Amortisation ₹3 Lakh ₹3.03 Lakh ₹18,000 ₹3.07 Lakh ₹3.13 Lakh ₹3.08 Lakh ₹2.71 Lakh ₹2.54 Lakh
Other Expenses ₹57.48 Lakh ₹49.86 Lakh ₹57.29 Lakh ₹45.51 Lakh ₹63.5 Lakh ₹57.95 Lakh ₹56.27 Lakh ₹40.44 Lakh
Total Expenses ₹2.51 Cr ₹4.35 Cr ₹4.91 Cr ₹5.65 Cr ₹2.84 Cr ₹4.28 Cr ₹3.64 Cr ₹4.59 Cr
Profit Before Exceptional Items & Tax -₹35.62 Lakh ₹4.98 Lakh ₹7.14 Lakh ₹23.6 Lakh -₹49.44 Lakh -₹43.18 Lakh -₹34.37 Lakh -₹52.81 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹35.62 Lakh ₹4.98 Lakh ₹7.14 Lakh ₹23.6 Lakh -₹49.44 Lakh -₹43.18 Lakh -₹34.37 Lakh -₹52.81 Lakh
Total Tax Expense -₹93.95 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Net Profit ₹58.33 Lakh ₹4.98 Lakh ₹7.14 Lakh ₹23.6 Lakh -₹49.44 Lakh -₹43.18 Lakh -₹34.37 Lakh -₹52.81 Lakh
Other Comprehensive Income ₹8,000 ₹2,000 ₹35,000 ₹3.2 Lakh -₹8,000 ₹6,000 ₹5.71 Lakh -₹1.97 Lakh
Total Comprehensive Income ₹58.41 Lakh ₹5 Lakh ₹7.49 Lakh ₹26.8 Lakh -₹49.52 Lakh -₹43.12 Lakh -₹28.66 Lakh -₹54.78 Lakh
EBITDA (computed) -₹32.39 Lakh ₹8.02 Lakh ₹10.42 Lakh ₹26.7 Lakh -₹46.1 Lakh -₹40.09 Lakh -₹31.51 Lakh -₹50.27 Lakh
Basic EPS ₹1.95 ₹0.17 ₹0.25 ₹0.89 ₹-1.65 ₹-1.44 ₹-0.96 ₹-1.83
Diluted EPS ₹1.95 ₹0.17 ₹0.25 ₹0.89 ₹-1.65 ₹-1.44 ₹-0.96 ₹-1.83
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Brawn Biotech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Brawn Biotech Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 52.94%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.35%, retail and other public shareholders hold 46.71% of Brawn Biotech Limited. The company had 3,303 shareholders on record.

Promoters: 52.94%DII (Domestic Institutional): 0.35%Retail & Others: 46.71%
Mar 2026
QUARTER
52.94% Promoters
0.35% DII (Domestic Institutional)
46.71% Retail & Others
Promoter holding - history
Now 52.94% · Mar 2026High 53.72% · Jun 2023Low 52.94% · Mar 2026
51%52%53%54%55%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 53.72%Sep 2023: 53.72%Dec 2023: 53.72%Mar 2024: 53.64%Jun 2024: 53.64%Sep 2024: 53.64%Dec 2024: 53.64%Mar 2025: 53.66%Jun 2025: 53.66%Sep 2025: 53.66%Dec 2025: 53.39%Mar 2026: 52.94%53.72%52.94%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters52.94%53.39%53.66%53.66%53.66%53.64%
Public47.06%46.61%46.34%46.34%46.34%46.36%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters52.94%53.66%53.64%
Public47.06%46.34%46.36%
Promoter change (YoY, %pts)-0.72+0.02-

Charges & Borrowings of Brawn Biotech Limited

Open charges
₹0
Satisfied charges
₹30.28 Lakh
Breakdown by lending institutions
Punjab National Bank₹0.30 Cr
Latest charge details
DateLenderAmountStatus
21 Apr 2015 Punjab National Bank ₹6.74 Lakh Satisfied
21 Apr 2015 Punjab National Bank ₹6.74 Lakh Satisfied
09 Apr 2014 Punjab National Bank ₹14.6 Lakh Satisfied
01 Sep 2011 Punjab National Bank ₹2.2 Lakh Satisfied

Total charge records: 4 View all charges

Employees and EPFO Compliance at Brawn Biotech Limited

View historical data on people associated with Brawn Biotech Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Brawn Biotech Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Brawn Biotech Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Brawn Biotech Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Brawn Biotech Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Brawn Biotech Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Brawn Biotech Limited

MSME Payment Delays by Brawn Biotech Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Brawn Biotech Limited

Subsidiaries & Group Companies of Brawn Biotech Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Brawn Biotech Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Brawn Biotech Limited

MCA Filings & Documents of Brawn Biotech Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Brawn Biotech Limited

Activity
30 Sep 2025
Brawn Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Brawn Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Directors
27 Aug 2024
Mayank Jain was appointed as a Director on 27 Aug 2024 & has been associated with this company since 1 year 10 months.
Directors
27 Aug 2024
Pooja Jha was appointed as a Director on 27 Aug 2024 & has been associated with this company since 1 year 10 months.
Directors
05 Aug 2022
Pooja Pandey was appointed as a CFO on 05 Aug 2022 & has been associated with this company since 3 years 11 months.
Charges
20 Feb 2019
A charge registered on 21 Apr 2015 via Charge ID 10568782 with Punjab National Bank was fully satisfied on 20 Feb 2019.

Frequently Asked Questions about Brawn Biotech Limited

Brawn Biotech Limited is an active public limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 07 November 1985 (41+ years old) and is registered under CIN L74899DL1985PLC022468. Listed on BSE: 530207.

Brawn Biotech Limited reported revenue of ₹13.56 Cr for FY 2025 (down 18.00% YoY).

The current directors of Brawn Biotech Limited are:

The primary industry of Brawn Biotech Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Yes. Brawn Biotech Limited is listed on BSE with code 530207.

Brawn Biotech Limited can be reached at the registered office: First Floor C – 64 Lagpat Nagar – 1, Delhi, Delhi, India – 110024, or through the website brawnbiotech.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available